<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">Taken together, there is an urgent need for COVID-19 therapeutics due to the S-shaped curve expansion of the infections, widespread pandemic status, and global burden. Given the similarities between SARS-CoV-2 and other coronaviruses, and its relative ease of sample acquisition and study, it has been widely accepted that drug repositioning is a promising approach to make available an effective, safety-assured treatment in a timely manner. In this review, we summarize diagnostic approaches, risk groups, available treatment options, and drug repositioning studies related to COVID-19.</p>
